Regulatory Aspects for the Drugs and Chemicals Used in Food-Producing Animals in the European Union

Veterinary Toxicology: Basic and Clinical Principles: Third Edition

Volumn , Issue , 2018, Pages 103-131

  Anadón, Arturo ^a   Martínez Larrañaga, María R ^a   Ares, Irma ^a   Martínez, María A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Biocides; Carryover; Chemicals; Drugs; European Union; Feed additives; Food producing animals; Food safety; Maximum reside limits (MRLs); Regulations; Withdrawal period

Indexed keywords

EID: 85046834251     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-811410-0.00007-6     Document Type: Chapter

References (69)

1. Anadón A. The EU ban of antibiotics as feed additives. Alternatives and consumer safety. J. Vet. Pharmacol. Ther. 2006, 29(Suppl. 1):41-44.
2. Anadón A., Martínez-Larrañaga M.R. Residues of antimicrobial drugs and feed additives in animal products: regulatory aspects. Livestock Prod. Sci. 1999, 59(2-3):183-198.
3. Anadón A., Martínez M.A., Martínez M., de la cruz C.O., et al. Oral bioavailability, tissue distribution and depletion of flumequine in food producing animal, chicken for fattening. Food Chem. Toxicol. 2008, 46:662-670.
4. Anadón A., Martínez M.A., Martinez M., et al. Plasma and tissue depletion of florfenicol and florfenicol-amine in chickens. J. Agric. Food Chem. 2008, 56:11049-11056.
5. Anadón A., Martínez-Larrañaga M.R., Caballero V., et al. Chapter 2. Assessment of prebiotics and probiotics: an overview. Bioactive Foods in Promoting Health: Probiotics and Prebiotics 2010, 19-41. Elsevier Inc./Academic Press, San Diego, CA. R. Watson, V.R. Preedy (Eds.).
6. Anadón A., Suarez F.H., Martínez M.A., et al. Plasma disposition and tissue depletion of difloxacin and its metabolite sarafloxacin in the food producing animals, chicken for fattening. Food Chem. Toxicol. 2011, 49:441-449.
7. Anadón A., Gamboa F., Martínez M.A., et al. Pharmacokinetics and tissue depletion of chlortetracycline after multiple oral administration to chickens for fattening. Food Chem. Toxicol. 2012, 50:2714-2721.
8. Anadón A., Martínez M.A., Castellano V., Martínez-Larrañaga M.R. The role of in vitro methods as alternatives to animals in toxicity testing. Expert Opin. Metab. Toxicol. 2013, 10(1):1-13.
9. Anadón A., Martínez-Larrañaga M.R., Arés I., et al. Prebiotics and probiotics: an assessment of their safety and health benefits. Chapter 1. Probiotics, Prebiotics, and Synbiotics. Bioactive Foods in Promoting Health: Probiotics and Prebiotics 2016, 3-23. Elsevier Inc./Academic Press, San Diego, CA, ISBN: 978-0-12-802189-7. R. Watson, V.R. Preedy (Eds.).
10. Cerniglia C.E., Pineiro S.A., Kotarski S.F. An update discussion on the current assessment of the safety of veterinary antimicrobial drug residues in food with regard to their impact on the human intestinal microbiome. Drug Test Anal. 2016, 8(5-6):539-548.
11. Cummings J.H., Banwell J.G., Segal I., et al. The amount and composition of large bowel contents in man. Gastroenterology 1990, 5:408.
12. Dayan A.D. Allergy to antimicrobial residues in food: assessment of the risk to man. Vet. Microbiol. 1993, 35:213-226.
13. Dorne J.L., Fernández-Cruz M.L., Bertelsen U., et al. Risk assessment of coccidostatics during feed cross-contamination: animal and human health aspects. Toxicol. Appl. Pharmacol. 2011, 8(3):160-171.
14. EC, (1997). Commission Directive 97/6/EC of 30 January Commission Directive 97/6/EC of 30 January 1997 amending Council Directive 70/524/EEC concerning additives in feedingstuffs.
15. EC, (1998a). Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (OJ L 123, 24.4.1998).
16. EC, (1998b). Council Regulation (EC) No 2821/98 of 17 December 1998 amending, as regards withdrawal of the authorisation of certain antibiotics, Directive 70/524/EEC concerning additives in feedingstuffs (OJ L 351, 29.12.1998).
17. EC, (2001). Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to veterinary medicinal products (OJ L 136, 30.4.2004).
18. EC, (2002a). Opinion of the Scientific Committee on Veterinary Measures Relating to Public Health on Review of previous SCVPH opinions of 30 April 1999 and 3 May 2000 on the potential risks to human health from hormone residues in bovine meat and meat products (adopted on 10 April 2002).
19. EC, (2002b). Regulation (EC) No 178/2002 of The European Parliament and of the Council of 28 January2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety (OJ L 31, 1.2.2002).
20. EC, (2003). Regulation (EC) No. 1831/2003 (EC, 2003) of the European Parliament and of the Council of 22 September on additives for use in animal nutrition (OJ No. L 268 18.10.2003).
21. EC, (2004a). Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ L 136, 30.4.2004).
22. EC, (2004b). Directive 2004/28/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/82/EC on the Community code relating to veterinary medicinal products (OJ L 136, 30/04/2004).
23. EC, (2005). Regulation (EC) No. 183/2005 of the European parliament and of the council of 12 January 2005 laying down requirements of feed hygiene (OJ L35, 8.2.2005).
24. EC, (2006). Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006).
25. EC, (2008a). Directive 2008/97/EC of The European Parliament and of the Council of 19 November 2008 amending Council Directive 96/22/EC concerning the prohibition on the use in stock farming of certain substances having a hormonal or thyrostatic action and of beta-agonists (OJ L 318, 28.11.2008).
26. EC, (2008b). Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications and the assessment and the authorisation of feed additives (OJ No. L 133, 22.5.2008).
27. EC, (2009a). Commission Directive 2009/9/EC of 10 February 2009 amending Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to medicinal products for veterinary use (OJ L 44, 14.2.2009).
28. EC, (2009b). Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ L 309, 24.11.2009).
29. EC, (2009c). Commission Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 concerning laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No. 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No. 726/2004 of the European Parliament and of the Council (OJ L 152, 16.6.2009).
30. Edler L., Poirier K., Dourson M., et al. Mathematical modelling and quantitative methods. Food Chem. Toxicol. 2002, 40:283-326.
31. EEC, (1967). Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (OJ L 196, 16.8.1967).
32. EEC, (1970). Council Directive 70/524/EEC of 23 November 1970 concerning additives in feedingstuffs (OJ No L 270, 14.12.1970).
33. EEC, (1976). Council Directive of 27 July 1976 on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (76/769/EEC) (OJ L 262, 27.9.1976).
34. EEC, (1978). Council Directive 78/631/EEC of 26 June 1978 on the approximation of the laws of the Member States relating to the classification, packaging and labeling of dangerous preparations (pesticides) (OJ L 206, 29.7.1978).
35. EEC, (1990). Council Regulation 90/2377/EEC laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (OJ No L 224, 12.8.90).
36. EEC, (1993). Council Regulation (EEC) n° 793/93 of 23 March 1993 on the evaluation and control of the risks of existing substances (OJ L 84, 5.4.1993).
37. EFSA Cross-contamination of non-target feedingstuffs by narasin authorised for use as a feed additive. EFSA J. 2007, 552:1-35.
38. Ellis, R., (2004). U.S.F.D.A. Regulatory approach for control of residues of veterinary drugs. In: Technical Workshop on Residues of Veterinary Drugs Without ADI/MRL, Bangkok (Thailand), August 24-26, 2004.
39. EU, (2010). Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010).
40. EU, (2012). Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167; 27.6.2012).
41. FAO/WHO, (2004). Evaluation of certain veterinary drug residues in food. In: Seventy-Eighth Report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization (Technical Report Series, 988), Geneva.
42. FAO/WHO (2014). Evaluation of certain veterinary drug residues in food. Seventy-eighth report of the Joint FAO/WHO Expert Committee on Food Additives. Geneva: World Healt Organization (Technical Report Series, 988).
43. FDA, (2003). Guidance for Industry (No.3). General Principles for Evaluating the Safety of Compounds Used in Food-Producing Animals. http://www.fda.gov/cvm/guidance/published.htm.
44. FDA, (March 5, 2013). Guidance for Industry (No. 159). Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish a Microbiological ADI - VICH GL-36 (R).
45. Herbst A.L. Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy. J. Toxicol. Environ. Health 1976, (Suppl. 1):13-20.
46. Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 1971, 284:878-881.
47. Hurd D.R. Trimediazine BMP: a major advance in in-feed medication. Feed Compounder 1996, 16:38-39.
48. Kennedy D.G., Smyth W.G., Hewitt A., et al. Monensin carry-over into unmedicated broiler feeds. Analyst 1998, 123:2529-2533.
49. Lagier J.C., Million M., Hugon P., et al. Human gut microbiota: repertoire and variations. Front. Cell. Infect. Microbiol. 2012, 2:136.
50. Leeman W.R., Van der Berg K.J., Houben G.F. Transfer of chemicals from feed to animal products: the use of transfer factors in risk assessment. Food Addit. Contam. 2007, 24:1-13.
51. Lützow, M. (2004), Residues of veterinary drugs without ADI/MRL: what Codex and WTO rules apply? In: Technical Workshop on Residues of Veterinary Drugs Without ADI/MRL, Bangkok (Thailand), August 24-26, 2004.
52. Martinez-Navarro J.F. Food poisoning related to consumption of illicit β-agonist in liver. Lancet 1990, 336:1311.
53. McEvoy J.D.G., Smyth W.G., Kennedy D.G. Contamination of animal feedingstuffs with nicarbazin: investigations in a feed mill. Food Addit. Contam. 2003, 20(2):136-140.
54. Metzler M. Diethylstilbestrol. Reactive metabolites derived from a hormonally active compound. Biochemical Basis of Chemical Carcinogenesis 1984, 69-75. Raven Press, New York, NY. H. Greim, R. Jung, M. Kramer, H. Marquardt, F. Oesch (Eds.).
55. Meyers R. D.E.S. The Bitter Pill 1983, Seaview/Putnam, New York, NY.
56. Noser J., Wenk P., Sutter A., et al. Kokzidiostatika in Eiern, Geflügelfleisch und Futtermitteln: Eine Stichproben-Kontrolle über den Nordwestschweizer Markt. Mitt. Lebensmittelunters. Hyg. 2006, 97:107-120.
57. O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006, 7:688-693.
58. Paige J.C., Tollefson L., Miller M. Public health impact on drug residues in animal tissues. Vet. Hum. Toxicol. 1997, 39(3):162-169.
59. Pulse C., Lamaison D., Keck G., et al. Collective human food poisoning by clenbuterol residues in veal liver. Vet. Hum. Toxicol. 1991, 33(5):480-481.
60. Strauch, W. (2002). Causes and control of carry-over and cross-contamination. Kraftfutter/Feed Mag. 85 (4), 151-159 (Part 1); Kraftfutter/Feed Mag. 85 (6), 239-249 (Part 2).
61. Strauch W. Is contamination-free feed production realistic?. Feed Technol. 2003, 7(7):23-25.
62. Sundlof S.F. Human risks associated with drug residues in animals derived foods. J. Agromed. 1994, 1:5-22.
63. Taylor W. Risk associated with the exposure of human subjects to endogenous and exogenous anabolic steroids. Anabolic in Animal Production 1983, 273-287. Office International des Epizooties, Paris. F. Meissonier, J. Mitchell-Vigneron (Eds.).
64. WHO Guidelines for Predicting Dietary Intake of Pesticide Residues 1989, World Health Organization, Geneva, 24 pp.
65. WHO Guidelines for Predicting Dietary Intake of Pesticides 1997, World Health Organization, Geneva.
66. WHO Evaluation of certain veterinary drug residues in food. Sixty-Sixth Report of the Joint FAO/WHO Expert Committee on Food Additives 2006, 15-16. World Health Organization, Geneva.
67. WHO Pesticide Residues in Food: Guidance Document for WHO Monographers and Reviewers 2015, World Health Organization, WHO Core Assessment Group on Pesticides Residues, Geneva.
68. Woodward K.N. Hypersensitivity in humans and exposure to veterinary drugs. Vet. Hum. Toxicol. 1991, 33(2):160-172.
69. Ito S., Alcorn J. Xenobiotic transporter expression and function in the mammary gland. Adv. Drug Deliv. Rev. 2003, 55:653-665.